Boston Partners Lantheus Holdings, Inc. Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Boston Partners holds 254,529 shares of LNTH stock, worth $22.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

254,529

Previous 653,901 61.08%

Holding current value

$22.8 Million

Previous $52.5 Million 46.79%

% of portfolio

0.03%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$77.7 - $123.62 $31 Million - $49.4 Million	-399,372 Reduced 61.08%	254,529 $27.9 Million
Q2 2024 Aug 13, 2024	SELL	$58.87 - $83.05 $1.61 Million - $2.27 Million	-27,380 Reduced 4.02%	653,901 $52.5 Million
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $6.09 Million - $8.13 Million	119,156 Added 21.2%	681,281 $42.4 Million
Q4 2023 Feb 07, 2024	BUY	$55.6 - $77.89 $2.74 Million - $3.83 Million	49,195 Added 9.59%	562,125 $34.9 Million
Q3 2023 Nov 07, 2023	BUY	$60.27 - $90.75 $4.08 Million - $6.15 Million	67,729 Added 15.21%	512,930 $35.6 Million
Q2 2023 Aug 10, 2023	BUY	$82.41 - $99.65 $9.07 Million - $11 Million	110,067 Added 32.84%	445,201 $37.4 Million
Q1 2023 May 09, 2023	BUY	$47.76 - $82.86 $16 Million - $27.8 Million	335,134 New	335,134 $27.7 Million
Q3 2022 Nov 09, 2022	SELL	$61.42 - $86.29 $446,953 - $627,932	-7,277 Reduced 59.21%	5,013 $353,000
Q2 2022 Aug 10, 2022	SELL	$55.54 - $72.65 $2.84 Million - $3.72 Million	-51,165 Reduced 80.63%	12,290 $812,000
Q1 2022 May 10, 2022	SELL	$24.28 - $56.64 $1.39 Million - $3.23 Million	-57,103 Reduced 47.37%	63,455 $3.51 Million
Q4 2021 Feb 04, 2022	BUY	$22.54 - $30.44 $1.28 Million - $1.72 Million	56,577 Added 88.43%	120,558 $3.48 Million
Q3 2021 Nov 05, 2021	SELL	$24.23 - $28.59 $1.97 Million - $2.32 Million	-81,172 Reduced 55.92%	63,981 $1.64 Million
Q2 2021 Aug 12, 2021	SELL	$19.51 - $27.64 $1.03 Million - $1.46 Million	-52,953 Reduced 26.73%	145,153 $4.01 Million
Q1 2021 May 10, 2021	BUY	$13.77 - $21.66 $886,774 - $1.39 Million	64,399 Added 48.16%	198,106 $4.23 Million
Q4 2020 Feb 04, 2021	BUY	$10.75 - $14.91 $1.44 Million - $1.99 Million	133,707 New	133,707 $1.8 Million
Q4 2018 Feb 07, 2019	SELL	$12.68 - $19.01 $713,884 - $1.07 Million	-56,300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.1 - $16.35 $3.94 Million - $4.91 Million	-300,490 Reduced 84.22%	56,300 $842,000
Q2 2018 Aug 03, 2018	BUY	$13.65 - $18.7 $3.24 Million - $4.43 Million	237,090 Added 198.07%	356,790 $5.19 Million
Q1 2018 May 04, 2018	BUY	$14.85 - $24.3 $1.78 Million - $2.91 Million	119,700 New	119,700 $1.9 Million

Others Institutions Holding LNTH

# of Institutions

541

Shares Held

68.3M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.16B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account